Abiomed Ret. on assets
What is the Ret. on assets of Abiomed?
The Ret. on assets of Abiomed Inc. is 16.01%
What is the definition of Ret. on assets?
Return on assets indicates how profitable a company’s assets are in generating revenue. It is computed by dividing net income by average total assets.
ttm (trailing twelve months)
The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.
Ret. on assets of companies in the Health Care sector on NASDAQ compared to Abiomed
What does Abiomed do?
Abiomed Europe GmbH, Aachen / Germany, as affiliate of Abiomed Inc. headquartered in Danvers, Massachusetts, USA, is a leading medical technology company in the field of circulatory support. Its products aim to enable heart recovery by improving blood circulation and/or heart pump function.
Companies with ret. on assets similar to Abiomed
- Smith & Wesson Brands has Ret. on assets of 15.98%
- AAG has Ret. on assets of 15.98%
- Njtc has Ret. on assets of 15.98%
- United s has Ret. on assets of 15.98%
- Kilpest India has Ret. on assets of 15.99%
- Novartis AG has Ret. on assets of 16.00%
- Abiomed has Ret. on assets of 16.01%
- Prime Securities has Ret. on assets of 16.01%
- Bharti Infratel has Ret. on assets of 16.03%
- United Parcel Service has Ret. on assets of 16.03%
- United Parcel Service has Ret. on assets of 16.03%
- Draper Esprit plc has Ret. on assets of 16.04%
- Procter & Gamble Health has Ret. on assets of 16.05%